Novartis AG (NOVN) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.092x

Based on the latest financial reports, Novartis AG (NOVN) has a cash flow conversion efficiency ratio of 0.092x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF3.60 Billion ≈ $4.55 Billion USD) by net assets (CHF39.04 Billion ≈ $49.36 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Novartis AG to measure how much of total assets are equity-financed.

Novartis AG - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Novartis AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Novartis AG cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Novartis AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Novartis AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Arm Holdings plc American Depositary Shares NASDAQ:ARM	0.031x
Nestlé S.A F:NESM	0.137x
Toyota Motor Corporation MX:TMN	0.042x
CHINA CON.BANK ADR/20 YC1 F:C6TB	0.158x
American Express Company NYSE:AXP	0.112x
Citigroup Inc. NYSE:C	-0.103x
Nestle S.A. SW:NESN	0.334x
Thermo Fisher Scientific Inc NYSE:TMO	0.044x

Annual Cash Flow Conversion Efficiency for Novartis AG (1998–2025)

The table below shows the annual cash flow conversion efficiency of Novartis AG from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Novartis AG worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF46.52 Billion ≈ $58.81 Billion	CHF20.05 Billion ≈ $25.35 Billion	0.431x	+7.97%
2024-12-31	CHF44.13 Billion ≈ $55.79 Billion	CHF17.62 Billion ≈ $22.28 Billion	0.399x	+29.11%
2023-12-31	CHF46.75 Billion ≈ $59.10 Billion	CHF14.46 Billion ≈ $18.28 Billion	0.309x	+29.09%
2022-12-31	CHF59.42 Billion ≈ $75.13 Billion	CHF14.24 Billion ≈ $18.00 Billion	0.240x	+7.81%
2021-12-31	CHF67.82 Billion ≈ $85.75 Billion	CHF15.07 Billion ≈ $19.05 Billion	0.222x	-7.75%
2020-12-31	CHF56.67 Billion ≈ $71.64 Billion	CHF13.65 Billion ≈ $17.26 Billion	0.241x	-1.79%
2019-12-31	CHF55.55 Billion ≈ $70.23 Billion	CHF13.62 Billion ≈ $17.23 Billion	0.245x	+35.24%
2018-12-31	CHF78.69 Billion ≈ $99.49 Billion	CHF14.27 Billion ≈ $18.04 Billion	0.181x	+6.67%
2017-12-31	CHF74.23 Billion ≈ $93.84 Billion	CHF12.62 Billion ≈ $15.96 Billion	0.170x	+10.97%
2016-12-31	CHF74.89 Billion ≈ $94.68 Billion	CHF11.47 Billion ≈ $14.51 Billion	0.153x	-0.67%
2015-12-31	CHF77.12 Billion ≈ $97.50 Billion	CHF11.90 Billion ≈ $15.04 Billion	0.154x	-21.36%
2014-12-31	CHF70.84 Billion ≈ $89.57 Billion	CHF13.90 Billion ≈ $17.57 Billion	0.196x	+10.89%
2013-12-31	CHF74.47 Billion ≈ $94.15 Billion	CHF13.17 Billion ≈ $16.66 Billion	0.177x	-13.68%
2012-12-31	CHF69.26 Billion ≈ $87.57 Billion	CHF14.19 Billion ≈ $17.95 Billion	0.205x	-5.56%
2011-12-31	CHF65.94 Billion ≈ $83.37 Billion	CHF14.31 Billion ≈ $18.09 Billion	0.217x	+7.63%
2010-12-31	CHF69.77 Billion ≈ $88.21 Billion	CHF14.07 Billion ≈ $17.78 Billion	0.202x	-4.97%
2009-12-31	CHF57.46 Billion ≈ $72.65 Billion	CHF12.19 Billion ≈ $15.41 Billion	0.212x	+9.54%
2008-12-31	CHF50.44 Billion ≈ $63.77 Billion	CHF9.77 Billion ≈ $12.35 Billion	0.194x	+3.88%
2007-12-31	CHF49.40 Billion ≈ $62.45 Billion	CHF9.21 Billion ≈ $11.64 Billion	0.186x	-11.60%
2006-12-31	CHF41.29 Billion ≈ $52.21 Billion	CHF8.71 Billion ≈ $11.01 Billion	0.211x	-13.43%
2005-12-31	CHF33.16 Billion ≈ $41.93 Billion	CHF8.08 Billion ≈ $10.22 Billion	0.244x	+13.45%
2004-12-31	CHF31.32 Billion ≈ $39.59 Billion	CHF6.72 Billion ≈ $8.50 Billion	0.215x	-1.47%
2003-12-31	CHF30.52 Billion ≈ $38.58 Billion	CHF6.65 Billion ≈ $8.41 Billion	0.218x	+5.93%
2002-12-31	CHF28.34 Billion ≈ $35.82 Billion	CHF5.83 Billion ≈ $7.37 Billion	0.206x	+18.68%
2001-12-31	CHF25.56 Billion ≈ $32.31 Billion	CHF4.43 Billion ≈ $5.60 Billion	0.173x	-14.50%
2000-12-31	CHF22.89 Billion ≈ $28.94 Billion	CHF4.64 Billion ≈ $5.87 Billion	0.203x	+9.95%
1999-12-31	CHF23.51 Billion ≈ $29.72 Billion	CHF4.33 Billion ≈ $5.48 Billion	0.184x	-1.03%
1998-12-31	CHF22.96 Billion ≈ $29.02 Billion	CHF4.28 Billion ≈ $5.41 Billion	0.186x	--

About Novartis AG

SW:NOVN Switzerland Drug Manufacturers - General

Market Cap

$306.13 Billion

CHF242.14 Billion CHF

Market Cap Rank

#85 Global

#3 in Switzerland

Share Price

CHF126.90

Change (1 day)

-0.60%

52-Week Range

CHF92.37 - CHF130.50

All Time High

CHF130.50